SSE Ticker: 603233

Dashenlin Pharmaceutical Group Co., Ltd.

大参林

Authorized Representative: 柯云峰

Board: Main A

Industry Classification: Wholesale & Retail

Zhongsheng Ruichuang's 3CL protease inhibitor clinical trial application was accepted by NMPA, and domestic new crown drugs accelerated

Post date May 16, 2022 — 08:44 Post Lock

The 2021 annual report of the pharmaceutical and biological industry and the summary of the first quarter of 2022 performance: the overall growth resilience is more differentiated than the sub-segments_Oriental Fortune Network

Post date May 13, 2022 — 20:12 Post Lock

Investment hedging guide: U.S. inflation data in April exceeded expectations, Tonghua Jinma will welcome a large-scale lifting of the ban, and Poly Development’s April contract amount decreased by 40% year-on-year

Post date May 12, 2022 — 08:51 Post Lock

Dashenlin: 10,112,600 shares held by Ke Jinlong, one of the controlling shareholders, are pledged, accounting for 1.28% of the company's total share capital

Post date May 11, 2022 — 18:56 Post Lock

Dashenlin: 10.1126 million shares held by Ke Jinlong, one of the controlling shareholders, are pledged, accounting for 1.28% of the company's total share capital.

Post date May 11, 2022 — 18:55 Post Lock

5.10 Yiling Brand Day Scientific and technological innovation helps Chinese pharmaceutical brands go global

Post date May 11, 2022 — 18:36 Post Lock

Dashenlin (603233.SH): Controlling shareholder pledged 10.1126 million shares_Stock Information_Market Gold Online

Post date May 11, 2022 — 18:07 Post Lock

Da Shenlin: Ke Jinlong has pledged about 59.42 million shares in total – yqqlm

Post date May 11, 2022 — 17:47 Post Lock

Kaiyuan Securities: Continue to be optimistic about investment opportunities in the new crown testing, consumer medical and new crown drug industry chains

Post date May 10, 2022 — 10:07 Post Lock

Industry Observation Chain Pharmacy: Q1 business recovery is better than previously expected inflection point to see Q2 same store growth_Securities News_Finance Gold Online

Post date May 9, 2022 — 12:09 Post Lock

In order to expand the scale of 16 equity investment mergers and acquisitions during the year, the solvency of ordinary people is under pressure

Post date May 9, 2022 — 09:01 Post Lock

R&D expenses of A-share pharmaceutical companies increased by 306 sales expenses of over 100 million Stock Channel Hexun.com

Post date May 9, 2022 — 04:42 Post Lock

A-share pharmaceutical companies’ expenses magnifying glass during the period: Shanghai Pharmaceuticals spends 6.2 billion in advertising expenses, and BeiGene invests the most in R&D_Shenzhen Hotline

Post date May 8, 2022 — 21:55 Post Lock

A-share pharmaceutical company’s expenses magnifying glass during the period: Shanghai Pharmaceuticals spends 6.2 billion advertising expenses, BeiGene invests the most in R&D

Post date May 8, 2022 — 20:56 Post Lock

5 stocks with buy rating latest: Xingfa Group CFi.CN Zhongcai Network

Post date May 6, 2022 — 08:50 Post Lock

400 billion "Security Mao" evaporated 40 billion a day, how much did Feng Liu's 8.6 billion market value get hurt? Zhang Kun is also recruited, and he is also listed on the top ten tradable shareholders-Fund Channel-Hexun.com

Post date May 5, 2022 — 22:28 Post Lock

Pharmaceutical business sector strengthens

Post date May 5, 2022 — 10:49 Post Lock

Medicine: The new crown nucleic acid test is normalized, the economy is stabilized, and the business recovery of the leading companies in the high-prosperity track is optimistic after the epidemic period – yqqlm

Post date May 5, 2022 — 08:20 Post Lock

Celebrity private equity adjustment route in the first quarter exposed! Gao Yi and Feng Liu cut positions in pharmaceutical stocks, and Deng Xiaofeng bucked the trend and increased positions in these stocks… The "mysterious" private equity of Shigekura Moutai also took action – yqqlm

Post date May 3, 2022 — 03:25 Post Lock

Celebrity private equity adjustment routes in the first quarter are exposed! Gao Yi and Feng Liu cut positions in pharmaceutical stocks, and Deng Xiaofeng bucked the trend and increased positions in these stocks…-Finance-

Post date May 3, 2022 — 01:37 Post Lock

Want to see more data? Registered subscribers can see all the data.